Skip to main content

Table 2 Subject Characteristics

From: High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate

Characteristic Healthy controls (n=15) T2DM (n=15) T2DM-As (n=15)
Age, years 60.53±14.46 56.60±14.98 57.40±14.67
Sex, male/female 6:9 7:8 7:8
Fasting glucose (mmol/L) 5.29±0.35 7.47±2.05* 8.47±1.05*#
HbA1c (%) 5.05±0.35 7.39±0.75* 7.73±0.65*#
Triglycerides (mmol/L) 1.04±0.20 2.13±1.00* 2.72±0.59*#
Total cholesterol (mmol/L) 3.22±0.40 4.70±0.72* 5.31±0.33*#
HDL-c (mmol/L) 1.33±0.11 0.95±0.26* 0.93±0.17*
LDL-c (mmol/L) 1.96±0.23 2.93±0.79* 3.25±0.68*#
  1. Abbreviations: HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol. Values are described as means ± SD.
  2. *P<0.001 versus healthy controls.
  3. # P<0.001 versus T2DM.